3 papers
Alexandra Hospital, Athens, Greece
1 trialPhase 4100 people
1 trialPhase 460 people
Ottawa Hospital Research Institute
1 trialPhase 32,464 people
Harvard School of Public Health
1 trialPhase 3915 people
1 trialPhase 3476 people
Epsom and St Helier University Hospitals NHS Trust
2 trialsPhase 2/3490 people
1 trialPhase 2/3790 people
1 trialPhase 2/37 people
National Institute on AgingUS$3.3mNational Institute of Child Health and Human DevelopmentUS$341.9k
Cardiovascular Disease Risk Factors in At-Risk Hispanic Women following Pregnancy Complications
National Institute of Child Health and Human DevelopmentUniversity of Massachusetts AmherstUS$341.9k2022–2027
ApoE-Tau axis in preeclampsia, a severe pregnancy complication, and neurodegeneration
National Institute on AgingUniversity of Texas Med Br GalvestonUS$3.3m2026–2030
An analysis of placental tissue linked the pregnancy complication to shorter chromosome ends, DNA damage and cells that had stopped dividing.An analysis of placental tissue linked the pregnancy complication to shorter chromosome ends, DNA damage and cells that had stopped dividing.
Targeting CD38 or supplementing NAD+ precursors reduces placental aging and improves offspring metabolic health in models of delayed maternal age.Targeting CD38 or supplementing NAD+ precursors reduces placental aging and improves offspring metabolic health in models of delayed maternal age.